Latest News

3 “Strong Buy” Stocks to Watch as 2Q22 Kicks Off

Motley Fool

3 Biotech Stocks to Buy in April

Biotech stocks, in general, again performed dismally in the first quarter of 2022. Here’s why they chose Amgen (NASDAQ: AMGN), Jazz Pharmaceuticals (NASDAQ: JAZZ), and Novocure (NASDAQ: NVCR). David Jagielski (Amgen): With new COVID-19 cases down significantly from where they were at the start of the year, there’s optimism that hospitals and the economy as a whole can return to normal in the near future.

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News